Clinical Trial Update: Effect of Intravenous Immunglobulin (IVIG) After Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating intravenous immunoglobulin after acute myocardial infarction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: Oslo University Hospital | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED